• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Partnership to decrease antipsychotic medication use in nursing homes: impact at the state level.

作者信息

Mort Jane R, Sailor Ryan, Hintz Lori

出版信息

S D Med. 2014 Feb;67(2):67-9.

PMID:24624602
Abstract

In 2012, the Centers for Medicare & Medicaid Services (CMS) established a partnership among stakeholders to decrease the percentage of residents in nursing homes receiving an antipsychotic agent by 15 percent. This goal emanated from concerns including the large percentage of residents taking antipsychotic agents, the questionable use of antipsychotics (e.g., off-label use), the high cost of inappropriate antipsychotic use, and toxicity in patients with dementia (e.g., black box warning regarding mortality). The successful achievement of this goal is evaluated via quality measures, which are greatly influenced by changes in exclusion of residents from the population examined. The partnership is focused on optimizing use of antipsychotic agents by training clinicians on nonpharmacologic approaches, educating on the dangers of antipsychotic medication use and sharing data on antipsychotic medications. In South Dakota, these efforts have yielded a 12 percent relative reduction (21.3 percent to 18.7 percent) in the percent of residents prescribed antipsychotic agents from the second quarter of 2012 to the second quarter of 2013. Future efforts in South Dakota include a Nursing Home Quality Care Collaborative that involves the majority of facilities across the state learning from peers and national experts. The South Dakota Dementia Coalition includes 17 stakeholders who guide education activities and communicate these opportunities to their constituents.

摘要

相似文献

1
Partnership to decrease antipsychotic medication use in nursing homes: impact at the state level.
S D Med. 2014 Feb;67(2):67-9.
2
When nurses lead.当护士引领时。
J Gerontol Nurs. 2014 Jun;40(6):17-21. doi: 10.3928/00989134-20140425-01. Epub 2014 May 2.
3
An observational study of antipsychotic medication use among long-stay nursing home residents without qualifying diagnoses.一项针对无合格诊断的长期疗养院居民使用抗精神病药物情况的观察性研究。
J Psychiatr Ment Health Nurs. 2018 Oct;25(8):463-474. doi: 10.1111/jpm.12488. Epub 2018 Aug 2.
4
Psychotropic medication prescribing in assisted living and nursing home residents with dementia after the National Partnership.《全国伙伴关系协议后,痴呆症患者在辅助生活和养老院中的精神药物处方》
J Am Geriatr Soc. 2022 Dec;70(12):3513-3525. doi: 10.1111/jgs.18004. Epub 2022 Aug 19.
5
Association of the Centers for Medicare & Medicaid Services' National Partnership to Improve Dementia Care With the Use of Antipsychotics and Other Psychotropics in Long-term Care in the United States From 2009 to 2014.美国医疗保险和医疗补助服务中心的国家合作伙伴关系与 2009 年至 2014 年美国长期护理中抗精神病药物和其他精神药物使用的关联。
JAMA Intern Med. 2018 May 1;178(5):640-647. doi: 10.1001/jamainternmed.2018.0379.
6
Variation in antipsychotic treatment choice across US nursing homes.美国养老院中抗精神病药物治疗选择的差异。
J Clin Psychopharmacol. 2012 Feb;32(1):11-7. doi: 10.1097/JCP.0b013e31823f6f46.
7
Educating Nursing Home Staff in Dementia Sensitive Communication: Impact on Antipsychotic Medication Use.在痴呆症敏感沟通方面对养老院员工进行教育:对使用抗精神病药物的影响。
J Am Med Dir Assoc. 2018 Dec;19(12):1129-1132. doi: 10.1016/j.jamda.2018.09.030.
8
Improving dementia care: new initiatives, new opportunities.改善痴呆症护理:新举措,新机遇。
Consult Pharm. 2014 Jan;29(1):16-23. doi: 10.4140/TCP.n.2014.16.
9
Off-label use of second-generation antipsychotic agents among elderly nursing home residents.老年疗养院居民中第二代抗精神病药物的标签外使用。
Psychiatr Serv. 2010 Feb;61(2):130-6. doi: 10.1176/ps.2010.61.2.130.
10
Deficiency Citations on Inappropriate Psychotropics Use Related to Care for Behavioral Symptoms of Dementia.精神药物使用不当与痴呆行为症状护理相关的缺乏证据。
J Am Med Dir Assoc. 2022 Nov;23(11):1772-1779. doi: 10.1016/j.jamda.2022.04.006. Epub 2022 May 12.

引用本文的文献

1
State of Science: Bridging the Science-Practice Gap in Aging, Dementia and Mental Health.科学现状:弥合衰老、痴呆症和精神健康领域的科学实践差距
J Am Geriatr Soc. 2018 Apr;66 Suppl 1(Suppl 1):S28-S35. doi: 10.1111/jgs.15320.
2
Antipsychotic prescribing for Alzheimer's disease and related disorders in specialized settings from 2010 to 2014 in France: a repeated cross-sectional study.2010年至2014年法国专科医院中阿尔茨海默病及相关疾病的抗精神病药物处方情况:一项重复横断面研究。
Alzheimers Res Ther. 2017 Apr 26;9(1):34. doi: 10.1186/s13195-017-0256-8.
3
Agitation and Irritability in Alzheimer's Disease: Evidenced-Based Treatments and the Black-Box Warning.
阿尔茨海默病中的激越与易怒:循证治疗及黑框警告
Curr Psychiatry Rep. 2016 Jan;18(1):3. doi: 10.1007/s11920-015-0640-7.